Imaging Brain Microglial Activation Using Positron Emission Tomography and Translocator Protein-Specific Radioligands

International Review of Neurobiology

Volumn 101, Issue , 2011, Pages 19-39

  Owen, David R J ^a   Matthews, Paul M ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Microglia; Peripheral benzodiazepine receptor; Positron emission tomography; Translocator protein

Indexed keywords

CARRIER PROTEIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11;

ALZHEIMER DISEASE; BINDING AFFINITY; BOOK; CELL ACTIVATION; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; LIGAND BINDING; MICROGLIA; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS; NEUROIMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA;

EID: 80055083184     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387718-5.00002-X     Document Type: Chapter

References (105)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. Anholt R.R., De Souza E.B., Oster-Granite M.L., Snyder S.H. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 1985, 233:517-526.
3. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L.Y., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch. Gen. Psychiatry 1998, 55:225-232.
4. Banati R.B., Daniel S.E., Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 1998, 13:221-227.
5. Banati R.B., Goerres G.W., Myers R., Gunn R.N., Turkheimer F.E., Kreutzberg G.W., Brooks D.J., Jones T., Duncan J.S. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999, 53:2199-2203.
6. Banati R.B., Newcombe J., Gunn R.N., Cagnin A., Turkheimer F., Heppner F., Price G., Wegner F., Giovannoni G., Miller D.H., Perkin G.D., Smith T., et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000, 123(Pt 11):2321-2337.
7. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997, 388:878-881.
8. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr. Opin. Neurol. 2002, 15:239-245.
9. Bartels A.L., Willemsen A.T., Doorduin J., de Vries E.F., Dierckx R.A., Leenders K.L. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?. Parkinsonism Relat. Disord. 2010, 16:57-59.
10. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
11. Cagnin A., Kassiou M., Meikle S.R., Banati R.B. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics 2007, 4:443-452.
12. Cameron B., Landreth G.E. Inflammation, microglia, and Alzheimer's disease. Neurobiol. Dis. 2010, 37:503-509.
13. Canat X., Carayon P., Bouaboula M., Cahard D., Shire D., Roque C., Le F.G., Casellas P. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci. 1993, 52:107-118.
14. Charbonneau P., Syrota A., Crouzel C., Valois J.M., Prenant C., Crouzel M. Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 1986, 73:476-483.
15. Chauveau F., Boutin H., Van C.N., Dolle F., Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2304-2319.
16. Cifelli A., Arridge M., Jezzard P., Esiri M.M., Palace J., Matthews P.M. Thalamic neurodegeneration in multiple sclerosis. Ann. Neurol. 2002, 52:650-653.
17. Conway E.L., Gundlach A.L., Craven J.A. Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat. Neuroscience 1998, 82:805-817.
18. Cosenza-Nashat M., Zhao M.L., Suh H.S., Morgan J., Natividad R., Morgello S., Lee S.C. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol. Appl. Neurobiol. 2009, 35:306-328.
19. Debruyne J.C., Versijpt J., Van Laere K.J., De V.F., Keppens J., Strijckmans K., Achten E., Slegers G., Dierckx R.A., Korf J., De Reuck J.L. PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur. J. Neurol. 2003, 10:257-264.
20. Diorio D., Welner S.A., Butterworth R.F., Meaney M.J., Suranyi-Cadotte B.E. Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex. Neurobiol. Aging 1991, 12:255-258.
21. Doble A., Malgouris C., Daniel M., Daniel N., Imbault F., Basbaum A., Uzan A., Gueremy C., Le F.G. Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution. Brain Res. Bull. 1987, 18:49-61.
22. Doorduin J., de Vries E.F., Willemsen A.T., de Groot J.C., Dierckx R.A., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 2009, 50:1801-1807.
23. Dubois A., Benavides J., Peny B., Duverger D., Fage D., Gotti B., MacKenzie E.T., Scatton B. Imaging of primary and remote ischaemic and excitotoxic brain lesions: An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res. 1988, 445:77-90.
24. Edison P., Archer H.A., Gerhard A., Hinz R., Pavese N., Turkheimer F.E., Hammers A., Tai Y.F., Fox N., Kennedy A., Rossor M., Brooks D.J. Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 2008, 32:412-419.
25. Endres C.J., Pomper M.G., James M., Uzuner O., Hammoud D.A., Watkins C.C., Reynolds A., Hilton J., Dannals R.F., Kassiou M. Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans. J. Nucl. Med. 2009, 50:1276-1282.
26. Fookes C.J., Pham T.Q., Mattner F., Greguric I., Loc'h C., Liu X., Berghofer P., Shepherd R., Gregoire M.C., Katsifis A. Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J. Med. Chem. 2008, 51:3700-3712.
27. Fujimura Y., Zoghbi S.S., Simeon F.G., Taku A., Pike V.W., Innis R.B., Fujita M. Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06. J. Nucl. Med. 2009, 50:1047-1053.
28. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 1999, 51:629-650.
29. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 1995, 20:269-287.
30. Gerhard A., Banati R.B., Goerres G.B., Cagnin A., Myers R., Gunn R.N., Turkheimer F., Good C.D., Mathias C.J., Quinn N., Schwarz J., Brooks D.J. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003, 61:686-689.
31. Gerhard A., Watts J., Trender-Gerhard I., Turkheimer F., Banati R.B., Bhatia K., Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration. Mov. Disord. 2004, 19:1221-1226.
32. Gerhard A., Schwarz J., Myers R., Wise R., Banati R.B. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage 2005, 24:591-595.
33. Gerhard A., Pavese N., Hotton G., Turkheimer F., Es M., Hammers A., Eggert K., Oertel W., Banati R.B., Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 2006, 21:404-412.
34. Gerhard A., Trender-Gerhard I., Turkheimer F., Quinn N.P., Bhatia K.P., Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy. Mov. Disord. 2006, 21:89-93.
35. Giulian D., Corpuz M., Chapman S., Mansouri M., Robertson C. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J. Neurosci. Res. 1993, 36:681-693.
36. Gulyas B., Makkai B., Kasa P., Gulya K., Bakota L., Varszegi S., Beliczai Z., Andersson J., Csiba L., Thiele A., Dyrks T., Suhara T., et al. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Neurochem. Int. 2009, 54:28-36.
37. Guo Q., Brady M., Gunn R.N. A biomathematical modeling approach to central nervous system radioligand discovery and development. J. Nucl. Med. 2009, 50:1715-1723.
38. Henkel K., Karitzky J., Schmid M., Mader I., Glatting G., Unger J.W., Neumaier B., Ludolph A.C., Reske S.N., Landwehrmeyer G.B. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov. Disord. 2004, 19:817-821.
39. Hulshoff Pol H.E., Schnack H.G., Mandl R.C., van Haren N.E., Koning H., Collins D.L., Evans A.C., Kahn R.S. Focal gray matter density changes in schizophrenia. Arch. Gen. Psychiatry 2001, 58:1118-1125.
40. Ikoma Y., Yasuno F., Ito H., Suhara T., Ota M., Toyama H., Fujimura Y., Takano A., Maeda J., Zhang M.R., Nakao R., Suzuki K. Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106. J. Cereb. Blood Flow Metab. 2007, 27:173-184.
41. Imaizumi M., Briard E., Zoghbi S.S., Gourley J.P., Hong J., Fujimura Y., Pike V.W., Innis R.B., Fujita M. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage 2008, 39:1289-1298.
42. Itzhak Y., Baker L., Norenberg M.D. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 1993, 9:211-218.
43. Ji B., Maeda J., Sawada M., Ono M., Okauchi T., Inaji M., Zhang M.R., Suzuki K., Ando K., Staufenbiel M., Trojanowski J.Q., Lee V.M., et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J. Neurosci. 2008, 28:12255-12267.
44. Joshi S.N., Crutcher K.A. Rat microglia exhibit increased density on Alzheimer's plaques in vitro. Exp. Neurol. 1998, 149:42-50.
45. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
46. Kropholler M.A., Boellaard R., Schuitemaker A., Folkersma H., van Berckel B.N., Lammertsma A.A. Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies. J. Cereb. Blood Flow Metab. 2006, 26:1431-1441.
47. Krupinski J., Kaluza J., Kumar P., Kumar S. Immunocytochemical studies of cellular reaction in human ischemic brain stroke. MAB anti-CD68 stains macrophages, astrocytes and microglial cells in infarcted area. Folia Neuropathol. 1996, 34:17-24.
48. Kurumaji A., Wakai T., Toru M. Decreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenics. J. Neural Transm. 1997, 104:1361-1370.
49. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
50. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 2003, 100:8514-8519.
51. Maeda J., Higuchi M., Inaji M., Ji B., Haneda E., Okauchi T., Zhang M.R., Suzuki K., Suhara T. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007, 1157:100-111.
52. Mainero C., Benner T., Radding A., van der K.A., Jensen R., Rosen B.R., Kinkel R.P. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009, 73:941-948.
53. Matthews P.M., Comley R. Advances in the molecular imaging of multiple sclerosis. Expert Rev. Clin. Immunol. 2009, 5:765-777.
54. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988, 38:1285-1291.
55. Messmer K., Reynolds G.P. Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease. Neurosci. Lett. 1998, 241:53-56.
56. Miyoshi M., Shinotoh H., Wszolek Z.K., Strongosky A.J., Shimada H., Arakawa R., Higuchi M., Ikoma Y., Yasuno F., Fukushi K., Irie T., Ito H., et al. In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: a PET and MRI study. Parkinsonism Relat. Disord. 2010, 16:404-408.
57. Myers R., Manjil L.G., Frackowiak R.S., Cremer J.E. [3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex. Neurosci. Lett. 1991, 133:20-24.
58. Oh U., Fujita M., Ikonomidou V.N., Evangelou I.E., Matsuura E., Harberts E., Ohayon J., Pike V.W., Zhang Y., Zoghbi S.S., Innis R.B., Jacobson S. Translocator protein PET imaging for glial activation in multiple sclerosis. J. Neuroimmune Pharmacol. 2010, 6:354-361.
59. Okello A., Edison P., Archer H.A., Turkheimer F.E., Kennedy J., Bullock R., Walker Z., Kennedy A., Fox N., Rossor M., Brooks D.J. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 2009, 72:56-62.
60. Ouchi Y., Yoshikawa E., Sekine Y., Futatsubashi M., Kanno T., Ogusu T., Torizuka T. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 2005, 57:168-175.
61. Owen D.R., Howell O.W., Tang S.P., Wells L.A., Bennacef I., Bergstrom M., Gunn R.N., Rabiner E.A., Wilkins M.R., Reynolds R., Matthews P.M., Parker C.A. Two binding sites for [(3)H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J. Cereb. Blood Flow Metab. 2010.
62. Owen D.R., Gunn R.N., Rabiner E.A., Bennacef I., Fujita M., Kreisl W.C., Innis R.B., Pike V.W., Reynolds R., Matthews P.M., Parker C.A. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J. Nucl. Med. 2011, 52:24-32.
63. Pappata S., Levasseur M., Gunn R.N., Myers R., Crouzel C., Syrota A., Jones T., Kreutzberg G.W., Banati R.B. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 2000, 55:1052-1054.
64. Pavese N., Gerhard A., Tai Y.F., Ho A.K., Turkheimer F., Barker R.A., Brooks D.J., Piccini P. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 2006, 66:1638-1643.
65. Petit-Taboue M.C., Baron J.C., Barre L., Travere J.M., Speckel D., Camsonne R., MacKenzie E.T. Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. Eur. J. Pharmacol. 1991, 200:347-351.
66. Politis M., Giannetti P., Su P., Turkheimer F., Keihaninejad S., Wu K., Waldman A., Reynolds R., Nicholas R., Piccini P. Cortical microglial activation is associated with disability in Secondary progressive Multiple Sclerosis: an in vivo imaging study. Neurology 2010, 74(Suppl. 2):A290.
67. Price C.J., Wang D., Menon D.K., Guadagno J.V., Cleij M., Fryer T., Aigbirhio F., Baron J.C., Warburton E.A. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke 2006, 37:1749-1753.
68. Radewicz K., Garey L.J., Gentleman S.M., Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 2000, 59:137-150.
69. Radlinska B.A., Ghinani S.A., Lyon P., Jolly D., Soucy J.P., Minuk J., Schirrmacher R., Thiel A. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann. Neurol. 2009, 66:825-832.
70. Raghavendra R.V., Dogan A., Bowen K.K., Dempsey R.J. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp. Neurol. 2000, 161:102-114.
71. Ramsay S.C., Weiller C., Myers R., Cremer J.E., Luthra S.K., Lammertsma A.A., Frackowiak R.S. Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 1992, 339:1054-1055.
72. Rao S.M., Leo G.J., Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991, 41:685-691.
73. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus T., Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 1999, 56:649-654.
74. Rey C., Mauduit C., Naureils O., Benahmed M., Louisot P., Gasnier F. Up-regulation of mitochondrial peripheral benzodiazepine receptor expression by tumor necrosis factor alpha in testicular leydig cells. Possible involvement in cell survival. Biochem. Pharmacol. 2000, 60:1639-1646.
75. Sapp E., Kegel K.B., Aronin N., Hashikawa T., Uchiyama Y., Tohyama K., Bhide P.G., Vonsattel J.P., DiFiglia M. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 2001, 60:161-172.
76. Schroeter M., Jander S., Witte O.W., Stoll G. Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex. Neuroscience 1999, 89:1367-1377.
77. Shah F., Hume S.P., Pike V.W., Ashworth S., McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl. Med. Biol. 1994, 21:573-581.
78. Sitte H.H., Wanschitz J., Budka H., Berger M.L. Autoradiography with [3H]PK11195 of spinal tract degeneration in amyotrophic lateral sclerosis. Acta Neuropathol. 2001, 101:75-78.
79. Steiner J., Mawrin C., Ziegeler A., Bielau H., Ullrich O., Bernstein H.G., Bogerts B. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006, 112:305-316.
80. Stephenson D.T., Schober D.A., Smalstig E.B., Mincy R.E., Gehlert D.R., Clemens J.A. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 1995, 15:5263-5274.
81. Tai Y.F., Pavese N., Gerhard A., Tabrizi S.J., Barker R.A., Brooks D.J., Piccini P. Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 2007, 130:1759-1766.
82. Takaya S., Hashikawa K., Turkheimer F.E., Mottram N., Deprez M., Ishizu K., Kawashima H., Akiyama H., Fukuyama H., Banati R.B., Roncaroli F. The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas. J. Neurooncol 2007, 85:95-103.
83. Thie J.A. Understanding the standardized uptake value, its methods, and implications for usage. J. Nucl. Med. 2004, 45:1431-1434.
84. Thiel A., Radlinska B.A., Paquette C., Sidel M., Soucy J.P., Schirrmacher R., Minuk J. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke. J. Nucl. Med. 2010, 51:1404-1412.
85. Tomasi G., Edison P., Bertoldo A., Roncaroli F., Singh P., Gerhard A., Cobelli C., Brooks D.J., Turkheimer F.E. Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. J. Nucl. Med. 2008, 49:1249-1256.
86. Tomimoto H., Akiguchi I., Wakita H., Kinoshita A., Ikemoto A., Nakamura S., Kimura J. Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol. 1996, 92:281-287.
87. Trincavelli M.L., Marselli L., Falleni A., Gremigni V., Ragge E., Dotta F., Santangelo C., Marchetti P., Lucacchini A., Martini C. Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets. J. Cell. Biochem. 2002, 84:636-644.
88. Turkheimer F.E., Edison P., Pavese N., Roncaroli F., Anderson A.N., Hammers A., Gerhard A., Hinz R., Tai Y.F., Brooks D.J. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J. Nucl. Med. 2007, 48:158-167.
89. van Berckel B.N., Bossong M.G., Boellaard R., Kloet R., Schuitemaker A., Caspers E., Luurtsema G., Windhorst A.D., Cahn W., Lammertsma A.A., Kahn R.S. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64:820-822.
90. Van C.N., Boisgard R., Kuhnast B., Theze B., Viel T., Gregoire M.C., Chauveau F., Boutin H., Katsifis A., Dolle F., Tavitian B. In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model. Eur. J. Nucl. Med. Mol. Imaging 2010.
91. Venneti S., Lopresti B.J., Wiley C.A. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog. Neurobiol. 2006, 80:308-322.
92. Venneti S., Wang G., Nguyen J., Wiley C.A. The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J. Neuropathol. Exp. Neurol. 2008, 67:1001-1010.
93. Vercellino M., Merola A., Piacentino C., Votta B., Capello E., Mancardi G.L., Mutani R., Giordana M.T., Cavalla P. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J. Neuropathol. Exp. Neurol. 2007, 66:732-739.
94. Versijpt J., Debruyne J.C., Van Laere K.J., De V.F., Keppens J., Strijckmans K., Achten E., Slegers G., Dierckx R.A., Korf J., De Reuck J.L. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult. Scler. 2005, 11:127-134.
95. Vowinckel E., Reutens D., Becher B., Verge G., Evans A., Owens T., Antel J.P. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1997, 50:345-353.
96. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
97. Watanabe H., Abe H., Takeuchi S., Tanaka R. Protective effect of microglial conditioning medium on neuronal damage induced by glutamate. Neurosci. Lett. 2000, 289:53-56.
98. Wiley C.A., Lopresti B.J., Venneti S., Price J., Klunk W.E., DeKosky S.T., Mathis C.A. Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch. Neurol. 2009, 66:60-67.
99. Wilson A.A., Garcia A., Parkes J., McCormick P., Stephenson K.A., Houle S., Vasdev N. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl. Med. Biol. 2008, 35:305-314.
100. Wood P.L. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol. Res. 1995, 17:242-248.
101. Yasuno F., Ota M., Kosaka J., Ito H., Higuchi M., Doronbekov T.K., Nozaki S., Fujimura Y., Koeda M., Asada T., Suhara T. Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. Biol. Psychiatry 2008, 64:835-841.
102. Yokokura M., Mori N., Yagi S., Yoshikawa E., Kikuchi M., Yoshihara Y., Wakuda T., Sugihara G., Takebayashi K., Suda S., Iwata Y., Ueki T., et al. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:343-351.
103. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. USA 1998, 95:15769-15774.
104. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. USA 1999, 96:13496-13500.
105. Zhang Z., Chopp M., Powers C. Temporal profile of microglial response following transient (2 h) middle cerebral artery occlusion. Brain Res. 1997, 744:189-198.